文献速递泌尿男性生殖肿瘤

中高复杂度肾肿瘤患者开放与机器人辅助部分肾切除术比较:随机对照开放标签多中心OpeRa试验最终结果

Open versus robotic-assisted partial nephrectomy in patients with intermediate/high-complexity kidney tumours: final results of the randomised, controlled, open-label, multicentre trial OpeRa.
PubMed 文献 · Ann Oncol · 2025-04-16

OpeRa试验将240例RENAL评分≥7的肾肿瘤患者随机分至机器人辅助部分肾切除术(RAPN)或开放部分肾切除术(OPN),因招募缓慢提前终止。30天并发症率RAPN 41/112(37%)vs OPN 41/89(46%),差异-9.5%(95%CI -23.1%至4.2%),无统计学显著差异。RAPN手术时间及热缺血时间更长、住院更短,恢复更好、阿片类用药及疼痛更少、生活质量更优。

要点

  • RAPN与OPN的30天并发症率无统计学显著差异(37% vs 46%,P=0.088)。
  • RAPN手术时间和热缺血时间更长,但住院时间更短。
  • RAPN患者疼痛更少、阿片类用药更少、恢复更好、生活质量更优。

核心结论

  • 在这项把握度不足的试验中,RAPN与OPN的30天并发症率无统计学显著差异。
  • 整个中高复杂度肿瘤队列中严重并发症少见。
  • 尽管疼痛管理强度较低,RAPN患者至术后第30天报告疼痛更少且生活质量更好。

研究设计与样本

  • 前瞻性、随机、开放标签、多中心OpeRa试验(NCT03849820),在12家德国医院开展。
  • 纳入年龄≥18岁、适合OPN或RAPN、RENAL评分≥7、估算肾小球滤过率≥50 ml/min/1.73 m2的患者。
  • 2019年3月15日至2021年11月23日随机,按1:1分配至RAPN或OPN。
  • 主要终点为改良意向治疗人群的30天术后并发症率(Clavien-Dindo I-V级)。
  • 计划招募606例患者以检测RAPN较OPN主要终点≥10%的降低。

主要发现

  • 共240例患者随机分配至RAPN(n=123)或OPN(n=117),因招募缓慢提前终止入组。
  • 随机后患者退出,最终117例接受RAPN、90例接受OPN;主要终点分别可评估112例和89例。
  • 30天并发症率RAPN 41/112(37%)vs OPN 41/89(46%)(单侧P=0.088)。
  • 差异为-9.5%(95%CI -23.1%至4.2%),数值上有利于RAPN。
  • 至术后第30天最常见的高级并发症(CD III-IV级)为尿漏[RAPN 4/112(4%)vs OPN 2/89(2%)]和术后出血[2/117(2%)vs 1/89(1%)]。

局限性

  • 因招募缓慢,入组提前终止。
  • 该试验把握度不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The prospective, randomised, open-label, multicentre OpeRa trial (NCT03849820) aimed to determine whether robotic-assisted partial nephrectomy (RAPN) is superior to open partial nephrectomy (OPN) in reducing 30-day post-operative complications during the treatment of intermediate/high-complexity renal tumours. PATIENTS AND METHODS: Eligible patients aged ≥18 years had a renal tumour suitable for OPN or RAPN, a RENAL score ≥7, and an estimated glomerular filtration rate ≥50 ml/min/1.73 m2. Patients were randomised from 15 March 2019 to 23 November 2021 in 12 German hospitals and assigned (1 : 1) to undergo RAPN or OPN. Primary endpoint was the 30-day post-operative complication rate [Clavien-Dindo (CD) I-V] in the modified intention-to-treat population. We aimed to recruit 606 patients to detect ≥10% reduction in the primary endpoint for RAPN versus OPN. RESULTS: A total of 240 patients were randomised to RAPN (n = 123) or OPN (n = 117). Enrolment was stopped prematurely due to slow recruitment. After patient withdrawal post-randomisation, 117 patients underwent RAPN and 90 OPN. The primary endpoint was assessable in 112 and 89 patients, respectively. The 30-day complication rate did not differ between groups: RAPN 41/112 (37%) versus OPN 41/89 (46%) (one-sided: P = 0.088). The difference of -9.5% (95% confidence interval -23.1% to 4.2%) numerically favoured RAPN. The most frequent high-grade complications (CD III-IV) to post-operative day 30 (POD30) were urine leakage [RAPN 4/112 (4%) versus OPN 2/89 (2%)] and post-operative bleeding [2/117 (2%) versus 1/89 (1%)]. Compared with OPN, RAPN patients had longer operative and warm ischaemia times, shorter hospital stay, and reported better recovery, less opioid use, less pain, and improved quality of life (QoL) up to POD30. CONCLUSIONS: There was no statistically significant difference in the 30-day complication rate between RAPN and OPN in this underpowered trial. Few high-grade complications occurred over the whole cohort with intermediate/high-complexity tumours. Despite less intense pain management, patients undergoing RAPN reported less pain and better QoL up to POD30.

来源:Ann Oncol,查看原文。版权归原作者所有。

引用

  1. Grimm MO, Bedke J, Nyarangi-Dix J, et al. Open versus robotic-assisted partial nephrectomy in patients with intermediate/high-complexity kidney tumours: final results of the randomised, controlled, open-label, multicentre trial OpeRa. Ann Oncol. 2025. PMID: 40250528. doi:10.1016/j.annonc.2025.04.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。